Hoffmann R, Jansen C, König A, Haager P K, Kerckhoff G, vom Dahl J, Klauss V, Hanrath P, Mudra H
Medical Clinic I, University Clinic RWTH Aachen, Pauwelstrasse 30, 52057 Aachen, Germany.
Eur Heart J. 2001 Nov;22(21):2007-14. doi: 10.1053/euhj.2001.2606.
Histological restenosis models in animals have indicated that stent design has a significant impact on vessel trauma during stent implantation and on the amount of subsequent neointimal tissue proliferation. The impact of different stent designs on intimal hyperplasia in human atherosclerotic coronary arteries has not been determined.
Angiographic and intravascular ultrasound studies were performed at the 6 month follow-up in 131 consecutive native coronary lesions of 131 patients treated with 50 Multi-Link stents, 40 InFlow stents and 41 Palmaz-Schatz stents. Lumen and stent cross-sectional areas (CSA) were measured at 1 mm axial increments. Mean intimal hyperplasia cross-sectional area (stent CSA-lumen CSA) and mean intimal hyperplasia thickness were calculated. Intravascular ultrasound demonstrated different levels of intimal hyperplasia proliferation for the three stents. Mean intimal hyperplasia thickness was 0.16+/-0.08 mm for Multi-Link stents, 0.26+/-0.19 mm for Palmaz-Schatz stents and 0.39+/-0.14 mm for Inflow stents (P<0.001). Multivariate analysis proved that stent type was the only independent predictor of intimal hyperplasia thickness at follow-up (P<0.001).
Coronary stent design has a significant impact on subsequent intimal hyperplasia after implantation into atherosclerotic human coronary arteries. The corrugated ring design of the Multi-Link stent proved to result in less tissue proliferation at 6-month follow-up than the tubular slotted design of Palmaz-Schatz and InFlow stents.
动物组织学再狭窄模型表明,支架设计对支架植入过程中的血管损伤以及随后的新生内膜组织增生量有重大影响。不同支架设计对人类动脉粥样硬化冠状动脉内膜增生的影响尚未确定。
对131例患者的131处连续的天然冠状动脉病变进行了6个月的随访,这些病变分别使用了50个多链接支架、40个InFlow支架和41个帕尔马茨-沙茨支架进行治疗。以1毫米的轴向增量测量管腔和支架的横截面积(CSA)。计算平均内膜增生横截面积(支架CSA-管腔CSA)和平均内膜增生厚度。血管内超声显示三种支架的内膜增生程度不同。多链接支架的平均内膜增生厚度为0.16±0.08毫米,帕尔马茨-沙茨支架为0.26±0.19毫米,InFlow支架为0.39±0.14毫米(P<0.001)。多变量分析证明,支架类型是随访时内膜增生厚度的唯一独立预测因素(P<0.001)。
冠状动脉支架设计对植入人类动脉粥样硬化冠状动脉后的内膜增生有重大影响。多链接支架的波纹环设计在6个月随访时比帕尔马茨-沙茨支架和InFlow支架的管状开槽设计导致更少的组织增生。